3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile

C22H23N9O — CID 166859841

IUPAC3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile
SMILESN#Cc1cccc([C@@H]2CC=NN2C(O)N2CCN(c3nccc(-c4ccn[nH]4)n3)CC2)c1
InChIInChI=1S/C22H23N9O/c23-15-16-2-1-3-17(14-16)20-6-9-26-31(20)22(32)30-12-10-29(11-13-30)21-24-7-4-18(27-21)19-5-8-25-28-19/h1-5,7-9,14,20,22,32H,6,10-13H2,(H,25,28)/t20-,22?/m0/s1
InChIKeyVDPRWDBPTWJMAC-AIBWNMTMSA-N
MW429.49 g/mol
LogP1.57
Rot. Bonds5

About 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile

3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile (PubChem CID 166859841) has the molecular formula C22H23N9O and a molecular weight of 429.49 g/mol. Its IUPAC name is 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile.

Molecular Properties

Compound Name3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile
PubChem CID166859841
Molecular FormulaC22H23N9O
Molecular Weight429.49 g/mol
Exact Mass429.20
IUPAC Name3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile
SMILESN#Cc1cccc([C@@H]2CC=NN2C(O)N2CCN(c3nccc(-c4ccn[nH]4)n3)CC2)c1
InChIInChI=1S/C22H23N9O/c23-15-16-2-1-3-17(14-16)20-6-9-26-31(20)22(32)30-12-10-29(11-13-30)21-24-7-4-18(27-21)19-5-8-25-28-19/h1-5,7-9,14,20,22,32H,6,10-13H2,(H,25,28)/t20-,22?/m0/s1
InChIKeyVDPRWDBPTWJMAC-AIBWNMTMSA-N
XLogP1.57
TPSA120.56 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500429.49
LogP ≤ 51.57
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile?
The IUPAC name of 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile (CID 166859841) is 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile.
What is the SMILES notation for 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile?
The canonical SMILES for 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile is N#Cc1cccc([C@@H]2CC=NN2C(O)N2CCN(c3nccc(-c4ccn[nH]4)n3)CC2)c1.
What is the InChIKey of 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile?
The InChIKey is VDPRWDBPTWJMAC-AIBWNMTMSA-N. The full InChI is InChI=1S/C22H23N9O/c23-15-16-2-1-3-17(14-16)20-6-9-26-31(20)22(32)30-12-10-29(11-13-30)21-24-7-4-18(27-21)19-5-8-25-28-19/h1-5,7-9,14,20,22,32H,6,10-13H2,(H,25,28)/t20-,22?/m0/s1.
What are the key properties of 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile?
3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile has a molecular weight of 429.49 g/mol, XLogP of 1.57, 5 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(3S)-2-[hydroxy-[4-[4-(1H-pyrazol-5-yl)pyrimidin-2-yl]piperazin-1-yl]methyl]-3,4-dihydropyrazol-3-yl]benzonitrile is sourced from PubChem (CID 166859841), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).